Literature DB >> 25724063

Obesity-induced lymphedema: clinical and lymphoscintigraphic features.

Arin K Greene1, Frederick D Grant, Sumner A Slavin, Reid A Maclellan.   

Abstract

UNLABELLED: The purpose of this study was to characterize obesity as a novel cause of lower extremity lymphedema. Fifty-one patients with a body mass index greater than 30 kg/m(2) without any potential cause of lymphedema were evaluated with lymphoscintigraphy. Group 1 patients (n = 33) were at their maximum body mass index; individuals with lymphatic dysfunction had a greater body mass index (72.0 kg/m(2)) compared with subjects with normal function (37.7 kg/m(2)) (p < 0.0001). Body mass index predicted the lymphoscintigram result, which was abnormal if the body mass index was greater than 60 kg/m(2) and normal if it was less than 50 kg/m(2). Group 2 patients (n = 18) had lost weight and were not at their maximum body mass index: patients who reduced their body mass index from greater than 60 kg/m to less than 50 kg/m(2) had normal (n = 4) or abnormal (n = 3) lymphatic function. Patients with obesity-induced lymphedema, or who were at risk for the condition, were referred to a surgical weight loss center. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

Entities:  

Mesh:

Year:  2015        PMID: 25724063     DOI: 10.1097/PRS.0000000000001271

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  14 in total

1.  Baseline Lymphatic Dysfunction Amplifies the Negative Effects of Lymphatic Injury.

Authors:  Geoffrey E Hespe; Catherine L Ly; Raghu P Kataru; Babak J Mehrara
Journal:  Plast Reconstr Surg       Date:  2019-01       Impact factor: 4.730

2.  Lifestyle Modification Group for Lymphedema and Obesity Results in Significant Health Outcomes.

Authors:  Leslyn Keith; Carol Rowsemitt; Lorie G Richards
Journal:  Am J Lifestyle Med       Date:  2017-11-21

3.  Postprandial lymphatic pump function after a high-fat meal: a characterization of contractility, flow, and viscosity.

Authors:  Timothy Kassis; Sri Charan Yarlagadda; Alison B Kohan; Patrick Tso; Victor Breedveld; J Brandon Dixon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-11       Impact factor: 4.052

4.  A Prospective Study on the Safety and Efficacy of Vascularized Lymph Node Transplant.

Authors:  Stav Brown; Babak J Mehrara; Michelle Coriddi; Leslie McGrath; Michele Cavalli; Joseph H Dayan
Journal:  Ann Surg       Date:  2022-07-15       Impact factor: 13.787

5.  Exploring disease interrelationships in patients with lymphatic disorders: A single center retrospective experience.

Authors:  Stanley G Rockson; Xin Zhou; Lan Zhao; Davood K Hosseini; Xinguo Jiang; Andrew J Sweatt; Dongeon Kim; Wen Tian; Michael P Snyder; Mark R Nicolls
Journal:  Clin Transl Med       Date:  2022-04

Review 6.  Diagnosis and Staging of Lymphedema.

Authors:  Arin K Greene; Jeremy A Goss
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

7.  Obesity-induced Lymphedema Nonreversible following Massive Weight Loss.

Authors:  Arin K Greene; Frederick D Grant; Reid A Maclellan
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-07-08

8.  Diagnostic Accuracy of Lymphoscintigraphy for Lymphedema and Analysis of False-Negative Tests.

Authors:  Aladdin H Hassanein; Reid A Maclellan; Frederick D Grant; Arin K Greene
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-12

9.  Roles of sarcoplasmic reticulum Ca2+ ATPase pump in the impairments of lymphatic contractile activity in a metabolic syndrome rat model.

Authors:  Yang Lee; Sanjukta Chakraborty; Mariappan Muthuchamy
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

10.  Lipidomic Profiling of Adipose Tissue Reveals an Inflammatory Signature in Cancer-Related and Primary Lymphedema.

Authors:  Lisa M Sedger; Dedreia L Tull; Malcolm J McConville; David P De Souza; Thusitha W T Rupasinghe; Spencer J Williams; Saravanan Dayalan; Daniel Lanzer; Helen Mackie; Thomas C Lam; John Boyages
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.